Author

V. Lindner

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Cell Biology· 1 Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Approach:experimental assay· 3 Research Focus:differential expression· 2 Research Focus:gene regulatory network inference· 2 Organism:human· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2

Frequent Co-Authors

H. Lang· 2 shared A. De Reynies· 1 shared A. Helleux· 1 shared A. Kamoun· 1 shared A. Poupeau· 1 shared A. R. Haller· 1 shared A. Ruiz-Villalba· 1 shared A. S. Loria· 1 shared

Activity by Year

2019-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 11 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

H. Lang

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Human Soluble Prorenin Receptor Expressed in Adipose Tissue Improves Insulin Sensitivity and Endothelial Function in Obese Female Mice

G. Arthur, N. Ahmed, K. Nichols, A. Poupeau, K. Collins, V. Lindner, A. S. Loria

This study shows that human sPRR expressed in adipose tissue improves insulin sensitivity and endothelial function in obese female mice, but not in males.

bioRxiv · Jan 12, 2024Physiology

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.

H. Lang, C. Beraud, L. Cabel, M. Lassalle, J. Fontugne, C. Krucker, F. Dufour, C. S. Groeneveld, V. Dixon, X. Meng, A. Kamoun, E. Chapeaublanc, A. De Reynies, X. Game, P. Rischmann, , T. Massfelder

The paper develops patient-derived xenografts (PDXs) for bladder and ureteral cancers, identifies molecular subtypes, and shows that combined FGFR/EGFR inhibition is more effective than single-agent therapy for FGFR3-mutant tumors.

Frontiers in Oncology · Aug 11, 2022Peer-reviewedCancer Biology

Integrative genomics uncover mechanisms of renal medullary carcinoma transformation, microenvironment landscape and therapeutic vulnerabilities.

B. H. Vokshi, G. Davidson, A. Helleux, M. Rippinger, A. R. Haller, J. Gantzer, P. Baltzinger, J. Thouvenin, R. Bouarich, V. Manriquez, S. Zaidi, P. Msaouel, X. Su, H. Lang, T. Tricard, , G. G. Malouf

This study uses single-cell and multi-region sequencing to define RMC transformation, identify cell states, and uncover therapeutic vulnerabilities through transcriptional changes and microenvironment interactions.

bioRxiv · Sep 29, 2021 · PreprintCancer Biology

Single-cell RNA-seq analysis reveals the crucial role of Collagen Triplex Helix Repeat Containing 1 (CTHRC1) cardiac fibroblasts for ventricular remodeling after myocardial infarction

A. Ruiz-Villalba, J. P. Romero, S. C. Hernandez, A. Vilas-Zornoza, N. Fortelny, L. Castro, P. San Martin-Uriz, E. Lorenzo-Vivas, P. Garcia-Olloqui, M. Palacios, J. J. Gavira, G. Bastarrika, S. Janssens, E. Iglesias, G. Abizanda, , F. Prosper

This study identifies a pro-fibrotic fibroblast subpopulation in mice after myocardial infarction, showing CTHRC1's role in ventricular remodeling and cardiac function.

bioRxiv · May 20, 2019Cell Biology